Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey

(2011) Joseph Muenzer et al.   GENETICS IN MEDICINE

Mucopolysaccharidosis type II: skeletal–muscle system involvement

(2011) Sandra Regina Morini et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B

Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II

(2010) Agnieszka Rozdzynska et al.   ACTA PAEDIATRICA

First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS)

(2010) C. Alcalde-Martín et al.   European Journal of Medical Genetics

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II

(2010) G. Schulze-Frenking et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study

(2009) JJ McGill et al.   CLINICAL GENETICS

Anthropometric data of 14 patients with mucopolysaccharidosis I: Retrospective analysis and efficacy of recombinant human α-l-iduronidase (laronidase)

(2009) Anna Tylki-Szymanska et al.   MOLECULAR GENETICS AND METABOLISM

Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-up

(2009) O. Gabrielli et al.   PEDIATRICS

Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)

(2008) R. Martin et al.   PEDIATRICS